Early [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic non-small cell lung cancer (NSCLC).

e19154 Background: Management of NSCLC patients may be guided by 18F-FDG-PET/CT for diagnostic, staging, prognostic value at diagnostic in stage I-IIIA, but its indication in the metastatic NSCLC i...